Class action lawsuits
Rosen Law Firm reminds investors of securities of Sarepta Therapeutics, Inc. between June 22, 2023, and June 24, 2025, of the important August 25, 2025, lead plaintiff deadline. The class action lawsuit alleges that Sarepta made false and misleading statements about its prescription gene therapy, ELEVIDYS, posing significant safety risks
Class action lawsuits
Rocket Pharmaceuticals, Inc. investors who bought the company's stocks between September 17, 2024, and May 26, 2025, may be affected by a class action securities lawsuit alleging securities fraud. The lawsuit claims that the company provided false and misleading statements about the safety and clinical trial protocol of
Class action lawsuits
A class action securities lawsuit has been filed against Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) alleging securities fraud between September 17, 2024, and May 26, 2025. The lawsuit claims that the company made false and misleading statements to investors about the safety and clinical trial protocol of its RP-A501 treatment, which
Class action lawsuits
The Rosen Law Firm, a global investor rights law firm, has filed a class action lawsuit on behalf of purchasers of Lockheed Martin Corporation (NYSE: LMT) securities between January 23, 2024, and July 21, 2025. The lawsuit claims that defendants made false and misleading statements and/or failed to disclose
Class action lawsuits
iRobot Corporation, a leading provider of robot vacuum cleaners and other robotic solutions, is facing a class action lawsuit alleging securities fraud between January 29, 2024, and March 11, 2025. The lawsuit claims that the company's management made false statements and concealed the truth about the restructuring plan&
Class action lawsuits
Fiserv, Inc.'s investors who suffered losses due to alleged securities fraud are seeking recovery under the federal securities laws. A class action lawsuit was filed against the company, alleging that it made false statements and concealed the true state of its business, particularly regarding its Payeezy and Clover
Class action lawsuits
Sarepta Therapeutics, Inc.'s (NASDAQ: SRPT) investors who suffered losses may be eligible to recover their losses under the federal securities laws. A class action lawsuit was filed against the company, alleging that it made false statements and concealed significant safety risks associated with its prescription gene therapy, ELEVIDYS.
Class action lawsuits
Neogen Corporation, a leading animal health company, has been hit with a class action lawsuit alleging securities fraud in connection with its integration with 3M Company's Food Safety Division. The lawsuit claims that Neogen made false and misleading statements to investors about the integration, leading to losses for
Class action lawsuits
Rosen Law Firm, a global investor rights law firm, has issued a notice reminding investors of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) to take action regarding a class action lawsuit filed against the company. The lawsuit claims that throughout the Class Period, defendants made false and
Class action lawsuits
Purchasers of Centene Corporation's securities between December 12, 2024, and June 30, 2025, may be entitled to compensation due to allegedly misleading statements about the company's enrollment, morbidity rates, and revenue guidance. A class action lawsuit has been filed, and investors have until September 8, 2025,
Class action lawsuits
Purchasers of securities of 3D Systems Corporation between August 13, 2024 and May 12, 2025, may be entitled to compensation without payment of any out-of-pocket fees or costs due to alleged false and/or misleading statements made by the company's defendants. A class action lawsuit has been filed
Class action lawsuits
The Rosen Law Firm, a global investor rights law firm, reminds investors of common stock of Neogen Corporation (NASDAQ: NEOG) to take action in a class action lawsuit. The action seeks to compensate investors who purchased the stock between January 5, 2023, and June 3, 2025. The deadline to join
